Iamgold Reports On Monster Lake Test Drilling

Iamgold Reports On Monster Lake Test Drilling

Iamgold, gold producer, said Thursday assay results from the winter 2017 drilling program were completed at its 50% owned Monster Lake joint-venture project in Quebec, Canada. The company said the results are from final fourteen drill holes, totaling just over 5,400 meters, from a total of 25 diamond drill holes, totaling 10,657 meters. The company described drill hole ML17-197 as: 3.5 meters grading 67.42 g/t gold and that includes 1.2 […]

Read More ˃
ConAgra Brands Meets Fiscal Q4 Street Views On EPS, Revenues

ConAgra Brands Meets Fiscal Q4 Street Views On EPS, Revenues

ConAgra Brands met Street views for its fiscal Q4 ended May 28, despite a decline in sales from the year-ago period. The branded-food purveyor reported fiscal Q4 adjusted EPS of $0.37, in line with the Street view as compiled by Capital IQ, and up from $0.32 reported a year earlier. The company reported fiscal Q4 sales of $1.86 billion, in line with Street views, although down from $2.05 billion a […]

Read More ˃
Bed Bath & Beyond Drops

Bed Bath & Beyond Drops

Bed Bath & Beyond shares dropped over 11% to the lowest since June 2009 on Friday after the omnichannel retailer reported late Thursday a worse-than-expected decline in its fiscal Q1 earnings. The new 52-week range is $29.59 to $48.83. EPS decreased to $0.53 for the three months ended May 27, including $0.05 per share related to an unfavorable impact from new share-based accounting, down from $0.80, a year ago. That […]

Read More ˃
Amec Foster Wheeler Gets Contract

Amec Foster Wheeler Gets Contract

Amec Foster Wheeler said Friday it has won an engineering procurement and construction contract from Gruyere Management Pty Ltd worth AUD298 million ($226.8 million) for the Gruyere gold project. The contract will be jointly executed by Amec Foster and Civmec Construction and Engineering as a joint venture, according to a statement Friday. The project, located about 200 kilometres east of Laverton, in Western Australia, is one of the largest undeveloped […]

Read More ˃
Zosano Pharma Presents Positive Data From Zotrip Study

Zosano Pharma Presents Positive Data From Zotrip Study

Zosano Pharma presented data on Saturday from its phase 2/3 Zotrip study for the acute treatment of migraines during the annual meeting of the American Headache Society in Boston. Data showed that the 3.8mg dose of M207 achieved both co-primary endpoints of pain freedom and most bothersome symptom freedom at 2 hours. In addition, the 3.8mg dose achieved significance in the secondary endpoints of pain freedom at 45 minutes and […]

Read More ˃